NICE will not recommend medical cannabis for epilepsy and chronic pain
The Pharmaceutical Journal Draft guidance says patients with chronic pain should not be offered tetrahydrocannabinol (THC) or mixtures of cannabidiol and THC unless the treatment is part of a clinical trial. The National Institute for Health and Care Excellence (NICE) has said it is currently unable… Read More »NICE will not recommend medical cannabis for epilepsy and chronic pain
